R

Ryvu Therapeutics SA
F:9Y4

Watchlist Manager
Ryvu Therapeutics SA
F:9Y4
Watchlist
Price: 4.115 EUR 1.11%
Market Cap: €95.1m

DCF Value

The DCF Value for Ryvu Therapeutics SA (9Y4) under the Base Case is -0.086 EUR. Compared with the current market price of 4.115 EUR, the stock appears Overvalued by 100% .

Key assumptions
9Y4 DCF Value
Base Case
-0.086
Overvaluation 100%
DCF Value
Price €4.115
Explore More DCF Valuations

Reverse DCF

Single-Assumption Reverse DCF
Stress-test one driver at a time

Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett